The promoting effect of glycolysis on AF and the pivotal enzyme in driving glycolysis are confirmed by treatment with glycolysis inhibitor 2‐deoxyglucose (2‐DG) and adeno‐associated virus‐mediated atrial PFKM expression. This evidence concerns the gene PFKM and atrial fibrillation.